Life360, Inc. — Director's Dealing 2025

Mar 12, 2025

==> picture [144 x 44] intentionally omitted <==

13 March 2025

SEC Form 4

Life360, Inc. (“Life360” or the “Company”) (NASDAQ: LIF, ASX: 360), the San Francisco Bay Areabased leader in family safety and connection, advises that the sales announced in the attached Forms 4 are US stock sales on the NASDAQ and pursuant to a Rule 10b5-1 trading plan.

A Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material non-public information about the Company.

Authorization

Russell Burke, Chief Financial Officer of Life360, authorized this announcement being given to ASX.

About Life360

Life360 delivers peace of mind for families of all types. The company’s category leading mobile app and Tile tracking devices help members protect the people, pets and things they care about most, with a range of services including location sharing, safe driver reports, and crash detection with emergency dispatch. Life360 is based in San Mateo and has approximately 61 million monthly active users (MAU) located in more than 150 countries. For more information, please visit life360.com and Tile.com.

Contacts

For Australian investor enquiries: For Australian media enquiries: Jolanta Masojada, +61 417 261 367 Giles Rafferty, +61 481 467 903 jmasojada@life360.com grafferty@firstadvisers.com.au For U.S. investors: For U.S. media inquiries: Investors@life360.com press@life360.com

Life360’s CDIs are issued in reliance on the exemption from registration contained in Regulation S of the US Securities Act of 1933 (Securities Act) for offers of securities which are made outside the US. Accordingly, the CDIs, have not been, and will not be, registered under the Securities Act or the laws of any state or other jurisdiction in the US. As a result of relying on the Regulation S exemption, the CDIs are ‘restricted securities’ under Rule 144 of the Securities Act. This means that you are unable to sell the CDIs into the US or to a US person who is not a QIB for the foreseeable future except in very limited circumstances until after the end of the restricted period, unless the re-sale of the CDIs is registered under the Securities Act or an exemption is available. To enforce the above transfer restrictions, all CDIs issued bear a FOR Financial Product designation on the ASX. This designation restricts any CDIs from being sold on ASX to US persons excluding QIBs. However, you are still able to freely transfer your CDIs on ASX to any person other than a US person who is not a QIB. In addition, hedging transactions with regard to the CDIs may only be conducted in accordance with the Securities Act.

Life360, Inc. | ARBN 629 412 942 | 1900 South Norfolk St, Suite 310 San Mateo, CA 94403 | investors.life360.com Page 1

SEC Form 4

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

OMB APPROVAL

OMB Number: 3235-0287 Estimated average burden hours per response: 0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for X the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) See Instruction 10.

==> picture [677 x 274] intentionally omitted <==

----- Start of picture text -----

1. Name and Address of Reporting Person [] 2. Issuer Name and Ticker or Trading Symbol 5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Burke Russell John Life360, Inc. [ LIF ] Director 10% Owner
(Last) (First) (Middle) 3. Date of Earliest Transaction (Month/Day/Year) X Officer (give title below) Other (specify below)
03/10/2025
Chief Financial Officer
C/O LIFE360, INC.
1900 SOUTH NORFOLK STREET, SUITE 310 4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line)
(Street) X Form filed by One Reporting Person
Form filed by More than One Reporting Person
SAN MATEO CA 94403
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction 2A. Deemed 3. 4. Securities Acquired (A) or Disposed Of (D) 5. Amount of Securities 6. 7. Nature of Indirect
Date Execution Date, Transaction (Instr. 3, 4 and 5) Beneficially Owned Ownership Beneficial Ownership
(Month/Day/Year) if any Code Following Reported Form: (Instr. 4)
(Month/Day/Year) (Instr. 8) Transaction(s) Direct (D)
(Instr. 3 and 4) or Indirect
Code V Amount (A) or Price (I) (Instr. 4)
(D)
Common stock 03/10/2025 M 20,000 A $ 3.58 188,065 (1) D
Common stock 03/10/2025 S 3,104 D $ 42.51 (3) 184,961 (1) D
(2)
----- End of picture text -----*

==> picture [677 x 179] intentionally omitted <==

----- Start of picture text -----

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative 2. Conver 3. Transaction 3A. Deemed 4. 5. Number 6. Date Exercisable 7. Title and Amount of 8. Price 9. Number 10. Own 11. Nature
Security (Instr. 3) sion or Date Execution Date, Transaction of and Expiration Date Securities Underlying of Deriv of ership of Indirect
Exercise (Month/Day/Year) if any Code Derivative (Month/Day/Year) Derivative Security ative derivative Form: Beneficial
Price of (Month/Day/Year) (Instr. 8) Securities (Instr. 3 and 4) Security Securities Direct Ownershi
Derivative Acquired (Instr. 5) Beneficially (D) or p (Instr. 4)
Security (A) or Owned Indirect (
Disposed of Following I) (Instr.
(D) (Instr. 3, Reported 4)
4 and 5) Transaction
(s) (Instr. 4)
Amount
Date Ex or
ercisab Expiration Number
Code V (A) (D) le Date Title of Shares
Stock Option (right $ 3.58 03/10/2025 M 20,0 (4) 05/19/2030 Common stock 20,000 $ 0.00 460,514 D
to buy) 00
----- End of picture text -----

Explanation of Responses:

1. Includes 106,756 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

3. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $42.25 to $43.00, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

4. The stock option vests and becomes exercisable as to 1/48th of the total number of shares in equal monthly installments beginning on June 19, 2020, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

Remarks:

/s/ Allison Chang, Attorney-in-Fact ** Signature of Reporting Person	03/12/2025
	Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

SEC Form 4

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

OMB APPROVAL

OMB Number: 3235-0287 Estimated average burden hours per response: 0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for X the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) See Instruction 10.

==> picture [677 x 348] intentionally omitted <==

----- Start of picture text -----

1. Name and Address of Reporting Person [] 2. Issuer Name and Ticker or Trading Symbol 5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Life360, Inc. [ LIF ]
Coghlan John Philip X Director 10% Owner
(Last) (First) (Middle) 3. Date of Earliest Transaction (Month/Day/Year) Officer (give title below) Other (specify below)
03/10/2025
C/O LIFE360, INC.
4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line)
1900 SOUTH NORFOLK STREET, SUITE 310
X Form filed by One Reporting Person
(Street)
Form filed by More than One Reporting Person
SAN MATEO CA 94403
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction 2A. Deemed 3. 4. Securities Acquired (A) or Disposed Of (D) 5. Amount of Securities 6. 7. Nature of Indirect
Date Execution Date, Transaction (Instr. 3, 4 and 5) Beneficially Owned Ownership Beneficial Ownership
(Month/Day/Year) if any Code Following Reported Form: (Instr. 4)
(Month/Day/Year) (Instr. 8) Transaction(s) Direct (D)
(Instr. 3 and 4) or Indirect
Code V Amount (A) or Price (I) (Instr. 4)
(D)
Held by the John
Common stock 03/10/2025 S(1) 3,125 D $ 42.53 (2) 35,669 I Coghlan Living
Trust
Held by The John
Philip Coghlan 2024
Common Stock 64,834 I
Grantor Retained
Annuity Trust
Common stock 5,226 (3) D
----- End of picture text -----*

==> picture [677 x 121] intentionally omitted <==

----- Start of picture text -----

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative 2. Convers 3. Transaction 3A. Deemed 4. 5. Number of 6. Date 7. Title and Amount of 8. Price 9. Number 10. Owne 11. Nature
Security (Instr. 3) ion or Date Execution Date, Transaction Derivative Exercisable and Securities Underlying of Deriva of derivative rship of Indirect
Exercise (Month/Day/Year) if any Code Securities Expiration Date Derivative Security tive Securities Form: Beneficial
Price of (Month/Day/Year) (Instr. 8) Acquired (A) (Month/Day/Year) (Instr. 3 and 4) Security Beneficially Direct Ownership
Derivative or Disposed (Instr. 5) Owned (D) or (Instr. 4)
Security of (D) (Instr. Following Indirect (
3, 4 and 5) Reported I) (Instr.
Transaction 4)
Date Ex Expira Amount or (s) (Instr. 4)
ercisabl tion Number of
Code V (A) (D) e Date Title Shares
----- End of picture text -----

Explanation of Responses:

1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024. The Rule 10b5-1 trading plan is a written, preestablished trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $42.25 to $43.00, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

3. Includes 1,742 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Remarks:

/s/ Jay Sood, as Attorney-in-Fact 03/12/2025 ** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.